Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C21H25N5O2.3ClH |
| Molecular Weight | 488.838 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.Cl.Cl.COC1=CC=CN=C1CCCCNC2=NC=C(CC3=CN=C(C)C=C3)C(=O)N2
InChI
InChIKey=NFXGPXPZKQLGKZ-UHFFFAOYSA-N
InChI=1S/C21H25N5O2.3ClH/c1-15-8-9-16(13-24-15)12-17-14-25-21(26-20(17)27)23-10-4-3-6-18-19(28-2)7-5-11-22-18;;;/h5,7-9,11,13-14H,3-4,6,10,12H2,1-2H3,(H2,23,25,26,27);3*1H
Icotidine (also known as SKF 93319) was developed as histamine H1- and H2-receptor antagonist and possessed antinociception properties. Due to its antagonist activity, was suggested that compound could have therapeutic in some inflammatory skin diseases such as the urticarias and mastocytosis.
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Icotidine, an antagonist of histamine at both H1 and H2 receptors. | 1986-03-01 |
|
| Cardiovascular studies with SK&F 93319, an antagonist of histamine at both H1- and H2-receptors. | 1984-10 |
|
| The pharmacokinetics in man of SK&F 93319--a new antagonist of histamine H1 and H2 receptors. | 1984-07 |
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Code | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID80221554
Created by
admin on Mon Mar 31 19:43:29 GMT 2025 , Edited by admin on Mon Mar 31 19:43:29 GMT 2025
|
PRIMARY | |||
|
71351-65-0
Created by
admin on Mon Mar 31 19:43:29 GMT 2025 , Edited by admin on Mon Mar 31 19:43:29 GMT 2025
|
PRIMARY | |||
|
130557
Created by
admin on Mon Mar 31 19:43:29 GMT 2025 , Edited by admin on Mon Mar 31 19:43:29 GMT 2025
|
PRIMARY | |||
|
U8GDC54XR4
Created by
admin on Mon Mar 31 19:43:29 GMT 2025 , Edited by admin on Mon Mar 31 19:43:29 GMT 2025
|
PRIMARY |
SUBSTANCE RECORD
